Cytochrome c oxidase (COX), or complex IV of the mitochondrial respiratory chain, is a copper- and hemecontaining metalloprotein composed of 13 subunits, 3 encoded by mitochondrial DNA (mtDNA) and 10 by nuclear DNA (nDNA). A number of COX-deficiency disorders are associated with point mutations in mtDNAencoded COX subunits, but very little is known regarding the molecular basis of mendelian-inherited COX deficiency disorders, which display widely varying phenotypes, including both generalized and tissuespecific clinical presentations. In particular, no mutation in any of the 10 nDNA-encoded COX subunits has yet been found. In the last four years, however, mutations have been found in four COX assembly genes - COX10 , SC01, SC02, and SURF1. We believe that other such genes exist, and propose to identify them by screening our large collection of fibroblasts from patients with COX deficiency. We propose to first, screen for """"""""obvious"""""""" candidate genes among the known COX structural and assembly genes. Among those cell lines which survive this first screen, we will use functional complementation by a combination of rodent-human monochromosomal hybrids and microcell-mediated chromosomal transfer to identify complementation groups and candidate chromosomal loci. The culprit genes at these loci will be identified by a combination of microsatelle and deletion mapping, coupled with a judicious sequencing of candidate genes in the region. Any new gene thus identified will be characterized as to its role in COX structure, function, and tissue-specific expression. Uncovering the molecular basis of COX deficiency will be useful in terms of pointing the way to diagnosis and treatment of these generally fatal and untreatable disorders. Moreover, these errors will be extremely useful in understanding fundamental biological phenomena, such as COX holoenzyme assembly, COX function, mitochondrial importation, and energy utilization and production. There are no naturally occurring COX mutants in higher eukaryotes other than those causing the diseases outlined above. Thus, elucidating the molecular basis of the COX deficiencies will afford us new and useful insights from both a clinical and scientific standpoint.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS011766-30
Application #
7557059
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
30
Fiscal Year
2006
Total Cost
$236,493
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Akman, H Orhan; Aykit, Yavuz; Amuk, Ozge Ceren et al. (2016) Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1. Neuromuscul Disord 26:16-20
Quinzii, Catarina M; Hirano, Michio; DiMauro, Salvatore (2014) Mutant COQ2 in multiple-system atrophy. N Engl J Med 371:81-2
Cámara, Yolanda; González-Vioque, Emiliano; Scarpelli, Mauro et al. (2014) Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. Hum Mol Genet 23:2459-67
Li, Wei; Gigante, Alba; Perez-Perez, Maria-Jesus et al. (2014) Thymidine phosphorylase participates in platelet signaling and promotes thrombosis. Circ Res 115:997-1006
Vara, Dina S; Campanella, Michelangelo; Canobbio, Ilaria et al. (2013) Autocrine amplification of integrin ?IIb?3 activation and platelet adhesive responses by deoxyribose-1-phosphate. Thromb Haemost 109:1108-19
Pfeffer, Gerald; Horvath, Rita; Klopstock, Thomas et al. (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9:474-81
Martí, Ramon; López, Luis C; Hirano, Michio (2012) Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity. Methods Mol Biol 837:121-33
Martí, Ramon; Dorado, Beatriz; Hirano, Michio (2012) Measurement of mitochondrial dNTP pools. Methods Mol Biol 837:135-48
Suomalainen, Anu; Elo, Jenni M; Pietiläinen, Kirsi H et al. (2011) FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol 10:806-18
Garone, Caterina; Tadesse, Saba; Hirano, Michio (2011) Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 134:3326-32

Showing the most recent 10 out of 81 publications